Interpretation of the expert consensus on traditional Chinese medicine diagnosis and treatment of irritable bowel syndrome(2024)
The expert consensus on traditional Chinese medicine diagnosis and treatment of irritable bowel syndrome(2024)is an expert consensus on traditional Chinese medicine(TCM)diagnosis and treatment led by the Spleen and Stomach Diseases Branch of the China Association of Chinese Medicine in November 2020 in Beijing,in collaboration with thirty tertiary hospitals and universities and research institutes across the country.It presents three important features:① it is comprehensive,covering the spectrum of irritable bowel syndrome(IBS)diagno-sis,etiology,pathogenesis,classification,clinical treatment protocols,efficacy assessment,advancements in TCM evidence-based medicine,preventative measures,and follow-up care,thereby offering an exhaustive guide for TCM practitioners in managing IBS.② it is cutting-edge,with additional sections that align with global diag-nostic and therapeutic frontiers,including an"Overview of Western Medicine Diagnosis and Treatment Progress","Progress of Evidence-Based Medicine in TCM",and an"Analysis of Challenges and Advantages of TCM".③it emphasizes experience inheritance and innovation,with a dedicated section on"Modern Academic Experience of Eminent TCM Practitioners".This article delves into the updates and highlights of the 2024 expert consensus,ai-ming to promote its broader clinical application.
irritable bowel syndrometraditional Chinese medicineexpert consensusinterpretation
万方数据
维普
